Sichuan Biokin reports H1 net loss of 1.6 billion yuan
Sichuan Biokin Pharmaceutical reported a H1 net loss of 1.6 billion yuan, per TradingView News.
Story updates
11:53:49 AM UTC
SquawkNews
Sichuan Biokin Pharmaceutical Co: Net loss deepened on surging R&D, but global first-in-class drug approvals marked a milestone
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.